SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4g4e'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_S_TRPS81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	ALA A 148 HIS A 164 ILE A 168 GLY A 156 THR A 2	None	1.14A	1utdS-4g4eA: undetectable 1utdT-4g4eA: undetectable	1utdS-4g4eA: 20.69 1utdT-4g4eA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_U_TRPU81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	ALA A 148 HIS A 164 ILE A 168 GLY A 156 THR A 2	None	1.18A	1utdU-4g4eA: undetectable 1utdV-4g4eA: undetectable	1utdU-4g4eA: 20.69 1utdV-4g4eA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_2_BO221405_1 (PROTEASOME COMPONENT PRE3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 148 SER A 124 GLY A 123 ALA A 121	None	1.22A	2f162-4g4eA: 20.3	2f162-4g4eA: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_K_BO2K1402_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 49	None	1.03A	2f16K-4g4eA: 20.9 2f16L-4g4eA: 17.7	2f16K-4g4eA: 28.05 2f16L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_K_BO2K1402_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 48	None	0.67A	2f16K-4g4eA: 20.9 2f16L-4g4eA: 17.7	2f16K-4g4eA: 28.05 2f16L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 148 SER A 124 GLY A 123 ALA A 121	None	1.22A	2f16N-4g4eA: 20.2	2f16N-4g4eA: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 49	None	1.04A	2f16Y-4g4eA: 21.0 2f16Z-4g4eA: 5.9	2f16Y-4g4eA: 28.05 2f16Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 48	None	0.68A	2f16Y-4g4eA: 21.0 2f16Z-4g4eA: 5.9	2f16Y-4g4eA: 28.05 2f16Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BRF_A_SORA2_0 (LIN-12 AND GLP-1 PHENOTYPE PROTEIN 1, ISOFORM A)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	3 / 3	LYS A 28 LYS A 32 VAL A 31	None	1.10A	3brfA-4g4eA: undetectable	3brfA-4g4eA: 15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_2_BO221405_1 (PROTEASOME COMPONENT PRE3 PROTEASOME COMPONENT PUP1)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 12	THR A 162 ALA A 148 SER A 124 GLY A 123 ALA A 121	None	1.15A	3mg02-4g4eA: 20.2 3mg0V-4g4eA: 21.9	3mg02-4g4eA: 21.83 3mg0V-4g4eA: 31.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MG0_H_BO2H1400_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.70A	3mg0H-4g4eA: 21.8 3mg0I-4g4eA: 19.7	3mg0H-4g4eA: 31.46 3mg0I-4g4eA: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_K_BO2K1402_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	8 / 11	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 ALA A 47 GLY A 48 SER A 124	None	0.58A	3mg0K-4g4eA: 21.0 3mg0L-4g4eA: 17.7	3mg0K-4g4eA: 28.05 3mg0L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_N_BO2N1404_1 (PROTEASOME COMPONENT PRE3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 148 SER A 124 GLY A 123 ALA A 121	None	1.16A	3mg0N-4g4eA: 20.3	3mg0N-4g4eA: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	8 / 12	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 ALA A 47 GLY A 48 SER A 124	None	0.61A	3mg0Y-4g4eA: 10.7 3mg0Z-4g4eA: 6.4	3mg0Y-4g4eA: 28.05 3mg0Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N9J_B_EAAB214_1 (GLUTATHIONE S-TRANSFERASE P)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 8	VAL A 34 GLY A 45 ILE A 122 GLY A 16	None	0.76A	3n9jB-4g4eA: undetectable	3n9jB-4g4eA: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WSJ_A_MK1A201_1 (PROTEASE)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	LEU A 142 ALA A 151 VAL A 6 LEU A 119 ILE A 147	None	1.46A	3wsjA-4g4eA: undetectable	3wsjA-4g4eA: 19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DUB_A_LDPA501_1 (CYTOCHROME P450 BM3 VARIANT 9D7)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 6	PHE A 60 ALA A 75 GLY A 69 LEU A 71	None	1.04A	4dubA-4g4eA: undetectable	4dubA-4g4eA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMB_A_SREA603_1 (TRANSPORTER)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	VAL A 4 ALA A 121 GLY A 156 SER A 124 GLY A 126	None	1.22A	4mmbA-4g4eA: undetectable	4mmbA-4g4eA: 15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMF_A_29QA603_1 (TRANSPORTER)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	VAL A 4 ALA A 121 GLY A 156 SER A 124 GLY A 126	None	1.28A	4mmfA-4g4eA: undetectable	4mmfA-4g4eA: 15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMF_B_29QB603_1 (TRANSPORTER)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	VAL A 4 ALA A 121 GLY A 156 SER A 124 GLY A 126	None	1.27A	4mmfB-4g4eA: undetectable	4mmfB-4g4eA: 15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.64A	4qvlK-4g4eA: 21.0 4qvlL-4g4eA: 17.7	4qvlK-4g4eA: 28.05 4qvlL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.01A	4qvlK-4g4eA: 21.0 4qvlL-4g4eA: 17.7	4qvlK-4g4eA: 28.05 4qvlL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.63A	4qvlY-4g4eA: 10.8 4qvlZ-4g4eA: 5.9	4qvlY-4g4eA: 28.05 4qvlZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.01A	4qvlY-4g4eA: 10.8 4qvlZ-4g4eA: 5.9	4qvlY-4g4eA: 28.05 4qvlZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.65A	4qvmK-4g4eA: 21.0 4qvmL-4g4eA: 17.6	4qvmK-4g4eA: 28.05 4qvmL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.01A	4qvmK-4g4eA: 21.0 4qvmL-4g4eA: 17.6	4qvmK-4g4eA: 28.05 4qvmL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.66A	4qvmY-4g4eA: 10.8 4qvmZ-4g4eA: 5.9	4qvmY-4g4eA: 28.05 4qvmZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.01A	4qvmY-4g4eA: 10.8 4qvmZ-4g4eA: 5.9	4qvmY-4g4eA: 28.05 4qvmZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.66A	4qvnK-4g4eA: 21.1 4qvnL-4g4eA: 17.7	4qvnK-4g4eA: 28.05 4qvnL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.66A	4qvnY-4g4eA: 10.8 4qvnZ-4g4eA: 18.7	4qvnY-4g4eA: 28.05 4qvnZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.64A	4qvpK-4g4eA: 20.9 4qvpL-4g4eA: 17.4	4qvpK-4g4eA: 28.05 4qvpL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.98A	4qvpK-4g4eA: 20.9 4qvpL-4g4eA: 17.4	4qvpK-4g4eA: 28.05 4qvpL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.64A	4qvpY-4g4eA: 10.8 4qvpZ-4g4eA: 18.8	4qvpY-4g4eA: 28.05 4qvpZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.97A	4qvpY-4g4eA: 10.8 4qvpZ-4g4eA: 18.8	4qvpY-4g4eA: 28.05 4qvpZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.67A	4qvqK-4g4eA: 21.0 4qvqL-4g4eA: 17.6	4qvqK-4g4eA: 28.05 4qvqL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.67A	4qvqY-4g4eA: 10.8 4qvqZ-4g4eA: 18.8	4qvqY-4g4eA: 28.05 4qvqZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 162 ALA A 15 ILE A 158 GLY A 125 ALA A 129	None	1.20A	4qvqY-4g4eA: 10.8 4qvqZ-4g4eA: 18.8	4qvqY-4g4eA: 28.05 4qvqZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.81A	4qvvH-4g4eA: 20.3	4qvvH-4g4eA: 26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 8	THR A 1 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.68A	4qvvK-4g4eA: 20.9 4qvvL-4g4eA: 17.6	4qvvK-4g4eA: 28.05 4qvvL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.80A	4qvvV-4g4eA: 22.0	4qvvV-4g4eA: 26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 8	THR A 1 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.68A	4qvvY-4g4eA: 10.7 4qvvZ-4g4eA: 4.5	4qvvY-4g4eA: 28.05 4qvvZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.66A	4qvwK-4g4eA: 21.0 4qvwL-4g4eA: 17.6	4qvwK-4g4eA: 28.05 4qvwL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.66A	4qvwY-4g4eA: 11.7 4qvwZ-4g4eA: 18.8	4qvwY-4g4eA: 28.05 4qvwZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.81A	4qvyH-4g4eA: 20.2	4qvyH-4g4eA: 26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 49	None	0.68A	4qvyK-4g4eA: 21.0 4qvyL-4g4eA: 17.7	4qvyK-4g4eA: 28.51 4qvyL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 VAL A 31 LYS A 33 GLY A 49 THR A 50	None	0.79A	4qvyK-4g4eA: 21.0 4qvyL-4g4eA: 17.7	4qvyK-4g4eA: 28.51 4qvyL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 49	None	0.67A	4qvyY-4g4eA: 21.0 4qvyZ-4g4eA: 4.7	4qvyY-4g4eA: 28.51 4qvyZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 VAL A 31 LYS A 33 GLY A 49 THR A 50	None	0.78A	4qvyY-4g4eA: 21.0 4qvyZ-4g4eA: 4.7	4qvyY-4g4eA: 28.51 4qvyZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 7	THR A 1 ALA A 20 LYS A 33 THR A 50	None	0.98A	4qw0K-4g4eA: 20.9	4qw0K-4g4eA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 7	THR A 1 ALA A 20 THR A 21 LYS A 33	None	0.57A	4qw0K-4g4eA: 20.9	4qw0K-4g4eA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 7	THR A 1 ALA A 20 LYS A 33 THR A 50	None	0.98A	4qw0Y-4g4eA: 10.7	4qw0Y-4g4eA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 7	THR A 1 ALA A 20 THR A 21 LYS A 33	None	0.57A	4qw0Y-4g4eA: 10.7	4qw0Y-4g4eA: 28.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.65A	4qw1K-4g4eA: 21.0 4qw1L-4g4eA: 17.7	4qw1K-4g4eA: 27.60 4qw1L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.99A	4qw1K-4g4eA: 21.0 4qw1L-4g4eA: 17.7	4qw1K-4g4eA: 27.60 4qw1L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.65A	4qw1Y-4g4eA: 10.8 4qw1Z-4g4eA: 17.5	4qw1Y-4g4eA: 27.60 4qw1Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.99A	4qw1Y-4g4eA: 10.8 4qw1Z-4g4eA: 17.5	4qw1Y-4g4eA: 27.60 4qw1Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.64A	4qw3K-4g4eA: 20.8 4qw3L-4g4eA: 17.6	4qw3K-4g4eA: 27.19 4qw3L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.02A	4qw3K-4g4eA: 20.8 4qw3L-4g4eA: 17.6	4qw3K-4g4eA: 27.19 4qw3L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.64A	4qw3Y-4g4eA: 10.6 4qw3Z-4g4eA: 18.7	4qw3Y-4g4eA: 27.19 4qw3Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	1.02A	4qw3Y-4g4eA: 10.6 4qw3Z-4g4eA: 18.7	4qw3Y-4g4eA: 27.19 4qw3Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 LYS A 33 GLY A 48 GLY A 49	None	1.04A	4qwuK-4g4eA: 20.1 4qwuL-4g4eA: 17.5	4qwuK-4g4eA: 28.05 4qwuL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.88A	4qwuK-4g4eA: 20.1 4qwuL-4g4eA: 17.5	4qwuK-4g4eA: 28.05 4qwuL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 LYS A 33 GLY A 48 GLY A 49	None	0.98A	4qwuY-4g4eA: 10.7 4qwuZ-4g4eA: 18.8	4qwuY-4g4eA: 28.05 4qwuZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.87A	4qwuY-4g4eA: 10.7 4qwuZ-4g4eA: 18.8	4qwuY-4g4eA: 28.05 4qwuZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.60A	5bxnK-4g4eA: 21.1 5bxnL-4g4eA: 17.4	5bxnK-4g4eA: 28.05 5bxnL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.99A	5bxnK-4g4eA: 21.1 5bxnL-4g4eA: 17.4	5bxnK-4g4eA: 28.05 5bxnL-4g4eA: 23.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5BXN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.77A	5bxnV-4g4eA: 22.0 5bxnW-4g4eA: 20.2	5bxnV-4g4eA: 31.46 5bxnW-4g4eA: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.61A	5bxnY-4g4eA: 10.8 5bxnZ-4g4eA: 18.7	5bxnY-4g4eA: 28.05 5bxnZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 162 ALA A 15 GLY A 125 GLY A 126 ALA A 129	None	0.99A	5bxnY-4g4eA: 10.8 5bxnZ-4g4eA: 18.7	5bxnY-4g4eA: 28.05 5bxnZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.57A	5d0xK-4g4eA: 21.0 5d0xL-4g4eA: 17.6	5d0xK-4g4eA: 27.60 5d0xL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.80A	5d0xV-4g4eA: 22.0	5d0xV-4g4eA: 26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.57A	5d0xY-4g4eA: 10.8 5d0xZ-4g4eA: 18.8	5d0xY-4g4eA: 27.60 5d0xZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_3_BEZ3801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 BEZ-LEU-LEU)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 4	LEU A 95 ILE A 105 GLY A 45 ILE A 120	None	0.80A	5dzk3-4g4eA: undetectable 5dzkm-4g4eA: undetectable	5dzk3-4g4eA: 2.11 5dzkm-4g4eA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_W_BEZW801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 5	ILE A 105 GLY A 45 ILE A 120 LEU A 95	None	0.87A	5dzkB-4g4eA: undetectable 5dzkI-4g4eA: undetectable 5dzkW-4g4eA: undetectable	5dzkB-4g4eA: 22.59 5dzkI-4g4eA: 21.74 5dzkW-4g4eA: 2.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_X_BEZX801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 BEZ-LEU-LEU)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 5	ILE A 105 GLY A 45 ILE A 120 LEU A 95	None	0.86A	5dzki-4g4eA: undetectable 5dzkj-4g4eA: undetectable 5dzkx-4g4eA: undetectable	5dzki-4g4eA: 21.74 5dzkj-4g4eA: 21.74 5dzkx-4g4eA: 2.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_Z_BEZZ801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 BEZ-LEU-LEU)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	4 / 4	ILE A 105 GLY A 45 ILE A 120 LEU A 95	None	0.79A	5dzkl-4g4eA: undetectable 5dzkz-4g4eA: undetectable	5dzkl-4g4eA: 21.74 5dzkz-4g4eA: 2.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 12	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.73A	5l5zH-4g4eA: 20.8 5l5zI-4g4eA: 19.6	5l5zH-4g4eA: 26.89 5l5zI-4g4eA: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.67A	5l5zK-4g4eA: 21.0 5l5zL-4g4eA: 17.5	5l5zK-4g4eA: 27.65 5l5zL-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 12	THR A 1 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.73A	5l5zV-4g4eA: 22.0 5l5zW-4g4eA: 20.1	5l5zV-4g4eA: 26.89 5l5zW-4g4eA: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 9	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.67A	5l5zY-4g4eA: 21.0 5l5zZ-4g4eA: 18.9	5l5zY-4g4eA: 27.65 5l5zZ-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.61A	5l66K-4g4eA: 21.1 5l66L-4g4eA: 17.7	5l66K-4g4eA: 23.61 5l66L-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48	None	0.62A	5l66Y-4g4eA: 21.1 5l66Z-4g4eA: 18.9	5l66Y-4g4eA: 23.61 5l66Z-4g4eA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_H_BO2H306_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 10	THR A 1 ALA A 20 THR A 21 ALA A 47 GLY A 48	None	0.65A	5lf3H-4g4eA: 22.0 5lf3I-4g4eA: 19.8	5lf3H-4g4eA: 24.57 5lf3I-4g4eA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_K_BO2K305_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-1)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	7 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49 TYR A 161	None	0.69A	5lf3K-4g4eA: 21.7 5lf3L-4g4eA: 18.8	5lf3K-4g4eA: 26.42 5lf3L-4g4eA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_V_BO2V303_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 10	THR A 1 ALA A 20 THR A 21 LYS A 33 ALA A 47 GLY A 48	None	0.70A	5lf3V-4g4eA: 22.0 5lf3W-4g4eA: 19.7	5lf3V-4g4eA: 24.57 5lf3W-4g4eA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_Y_BO2Y305_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-1)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	7 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49 TYR A 161	None	0.70A	5lf3Y-4g4eA: 21.7 5lf3Z-4g4eA: 18.8	5lf3Y-4g4eA: 26.42 5lf3Z-4g4eA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_H_6V8H305_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 ALA A 20 THR A 21 ALA A 47 GLY A 48	None	0.67A	5lf7H-4g4eA: 22.0 5lf7I-4g4eA: 19.7	5lf7H-4g4eA: 24.57 5lf7I-4g4eA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_K_6V8K305_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	7 / 11	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 48 GLY A 49	None	0.75A	5lf7K-4g4eA: 21.7 5lf7L-4g4eA: 18.8	5lf7K-4g4eA: 26.42 5lf7L-4g4eA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_V_6V8V303_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	5 / 11	THR A 1 ALA A 20 THR A 21 ALA A 47 GLY A 48	None	0.70A	5lf7V-4g4eA: 22.0 5lf7W-4g4eA: 19.8	5lf7V-4g4eA: 24.57 5lf7W-4g4eA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_Y_6V8Y306_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-5)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	7 / 11	THR A 1 ALA A 20 THR A 21 VAL A 31 LYS A 33 GLY A 48 GLY A 49	None	0.75A	5lf7Y-4g4eA: 21.7 5lf7Z-4g4eA: 18.8	5lf7Y-4g4eA: 26.42 5lf7Z-4g4eA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_K_BO2K301_0 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.62A	6hwdK-4g4eA: 21.0 6hwdL-4g4eA: 17.7	6hwdK-4g4eA: 22.09 6hwdL-4g4eA: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_Y_BO2Y301_0 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4g4e	ATP-DEPENDENT PROTEASE SUBUNIT HSLV (Escherichia coli)	6 / 11	THR A 1 ALA A 20 THR A 21 LYS A 33 GLY A 48 GLY A 49	None	0.61A	6hwdY-4g4eA: 10.9 6hwdZ-4g4eA: 17.5	6hwdY-4g4eA: 22.09 6hwdZ-4g4eA: 19.05

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UTD_S_TRPS81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A 148;HIS A 164;ILE A 168;GLY A 156;THR A   2","None","1.14A","1utdS-4g4eA:undetectable;1utdT-4g4eA:undetectable","1utdS-4g4eA:20.69;1utdT-4g4eA:20.69"],["1UTD_U_TRPU81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A 148;HIS A 164;ILE A 168;GLY A 156;THR A   2","None","1.18A","1utdU-4g4eA:undetectable;1utdV-4g4eA:undetectable","1utdU-4g4eA:20.69;1utdV-4g4eA:20.69"],["2F16_2_BO221405_1","PROTEASOME COMPONENT PRE3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A 148;SER A 124;GLY A 123;ALA A 121","None","1.22A","2f162-4g4eA:20.3","2f162-4g4eA:21.83"],["2F16_K_BO2K1402_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  49","None","1.03A","2f16K-4g4eA:20.9;2f16L-4g4eA:17.7","2f16K-4g4eA:28.05;2f16L-4g4eA:23.61"],["2F16_K_BO2K1402_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  48","None","0.67A","2f16K-4g4eA:20.9;2f16L-4g4eA:17.7","2f16K-4g4eA:28.05;2f16L-4g4eA:23.61"],["2F16_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A 148;SER A 124;GLY A 123;ALA A 121","None","1.22A","2f16N-4g4eA:20.2","2f16N-4g4eA:21.83"],["2F16_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  49","None","1.04A","2f16Y-4g4eA:21.0;2f16Z-4g4eA:5.9","2f16Y-4g4eA:28.05;2f16Z-4g4eA:23.61"],["2F16_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  48","None","0.68A","2f16Y-4g4eA:21.0;2f16Z-4g4eA:5.9","2f16Y-4g4eA:28.05;2f16Z-4g4eA:23.61"],["3BRF_A_SORA2_0","LIN-12 AND GLP-1 PHENOTYPE PROTEIN 1, ISOFORM A","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",3,"LYS A  28;LYS A  32;VAL A  31","None","1.10A","3brfA-4g4eA:undetectable","3brfA-4g4eA:15.61"],["3MG0_2_BO221405_1","PROTEASOME COMPONENT PRE3;PROTEASOME COMPONENT PUP1","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A 148;SER A 124;GLY A 123;ALA A 121","None","1.15A","3mg02-4g4eA:20.2;3mg0V-4g4eA:21.9","3mg02-4g4eA:21.83;3mg0V-4g4eA:31.46"],["3MG0_H_BO2H1400_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.70A","3mg0H-4g4eA:21.8;3mg0I-4g4eA:19.7","3mg0H-4g4eA:31.46;3mg0I-4g4eA:22.90"],["3MG0_K_BO2K1402_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",8,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;ALA A  47;GLY A  48;SER A 124","None","0.58A","3mg0K-4g4eA:21.0;3mg0L-4g4eA:17.7","3mg0K-4g4eA:28.05;3mg0L-4g4eA:23.61"],["3MG0_N_BO2N1404_1","PROTEASOME COMPONENT PRE3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A 148;SER A 124;GLY A 123;ALA A 121","None","1.16A","3mg0N-4g4eA:20.3","3mg0N-4g4eA:21.83"],["3MG0_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",8,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;ALA A  47;GLY A  48;SER A 124","None","0.61A","3mg0Y-4g4eA:10.7;3mg0Z-4g4eA:6.4","3mg0Y-4g4eA:28.05;3mg0Z-4g4eA:23.61"],["3N9J_B_EAAB214_1","GLUTATHIONE S-TRANSFERASE P","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"VAL A  34;GLY A  45;ILE A 122;GLY A  16","None","0.76A","3n9jB-4g4eA:undetectable","3n9jB-4g4eA:21.46"],["3WSJ_A_MK1A201_1","PROTEASE","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"LEU A 142;ALA A 151;VAL A   6;LEU A 119;ILE A 147","None","1.46A","3wsjA-4g4eA:undetectable","3wsjA-4g4eA:19.68"],["4DUB_A_LDPA501_1","CYTOCHROME P450 BM3 VARIANT 9D7","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"PHE A  60;ALA A  75;GLY A  69;LEU A  71","None","1.04A","4dubA-4g4eA:undetectable","4dubA-4g4eA:19.26"],["4MMB_A_SREA603_1","TRANSPORTER","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"VAL A   4;ALA A 121;GLY A 156;SER A 124;GLY A 126","None","1.22A","4mmbA-4g4eA:undetectable","4mmbA-4g4eA:15.16"],["4MMF_A_29QA603_1","TRANSPORTER","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"VAL A   4;ALA A 121;GLY A 156;SER A 124;GLY A 126","None","1.28A","4mmfA-4g4eA:undetectable","4mmfA-4g4eA:15.12"],["4MMF_B_29QB603_1","TRANSPORTER","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"VAL A   4;ALA A 121;GLY A 156;SER A 124;GLY A 126","None","1.27A","4mmfB-4g4eA:undetectable","4mmfB-4g4eA:15.12"],["4QVL_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.64A","4qvlK-4g4eA:21.0;4qvlL-4g4eA:17.7","4qvlK-4g4eA:28.05;4qvlL-4g4eA:23.61"],["4QVL_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.01A","4qvlK-4g4eA:21.0;4qvlL-4g4eA:17.7","4qvlK-4g4eA:28.05;4qvlL-4g4eA:23.61"],["4QVL_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.63A","4qvlY-4g4eA:10.8;4qvlZ-4g4eA:5.9","4qvlY-4g4eA:28.05;4qvlZ-4g4eA:23.61"],["4QVL_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.01A","4qvlY-4g4eA:10.8;4qvlZ-4g4eA:5.9","4qvlY-4g4eA:28.05;4qvlZ-4g4eA:23.61"],["4QVM_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.65A","4qvmK-4g4eA:21.0;4qvmL-4g4eA:17.6","4qvmK-4g4eA:28.05;4qvmL-4g4eA:23.61"],["4QVM_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.01A","4qvmK-4g4eA:21.0;4qvmL-4g4eA:17.6","4qvmK-4g4eA:28.05;4qvmL-4g4eA:23.61"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.66A","4qvmY-4g4eA:10.8;4qvmZ-4g4eA:5.9","4qvmY-4g4eA:28.05;4qvmZ-4g4eA:23.61"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.01A","4qvmY-4g4eA:10.8;4qvmZ-4g4eA:5.9","4qvmY-4g4eA:28.05;4qvmZ-4g4eA:23.61"],["4QVN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.66A","4qvnK-4g4eA:21.1;4qvnL-4g4eA:17.7","4qvnK-4g4eA:28.05;4qvnL-4g4eA:23.61"],["4QVN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.66A","4qvnY-4g4eA:10.8;4qvnZ-4g4eA:18.7","4qvnY-4g4eA:28.05;4qvnZ-4g4eA:23.61"],["4QVP_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.64A","4qvpK-4g4eA:20.9;4qvpL-4g4eA:17.4","4qvpK-4g4eA:28.05;4qvpL-4g4eA:23.61"],["4QVP_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.98A","4qvpK-4g4eA:20.9;4qvpL-4g4eA:17.4","4qvpK-4g4eA:28.05;4qvpL-4g4eA:23.61"],["4QVP_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.64A","4qvpY-4g4eA:10.8;4qvpZ-4g4eA:18.8","4qvpY-4g4eA:28.05;4qvpZ-4g4eA:23.61"],["4QVP_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.97A","4qvpY-4g4eA:10.8;4qvpZ-4g4eA:18.8","4qvpY-4g4eA:28.05;4qvpZ-4g4eA:23.61"],["4QVQ_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.67A","4qvqK-4g4eA:21.0;4qvqL-4g4eA:17.6","4qvqK-4g4eA:28.05;4qvqL-4g4eA:23.61"],["4QVQ_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.67A","4qvqY-4g4eA:10.8;4qvqZ-4g4eA:18.8","4qvqY-4g4eA:28.05;4qvqZ-4g4eA:23.61"],["4QVQ_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;ILE A 158;GLY A 125;ALA A 129","None","1.20A","4qvqY-4g4eA:10.8;4qvqZ-4g4eA:18.8","4qvqY-4g4eA:28.05;4qvqZ-4g4eA:23.61"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.81A","4qvvH-4g4eA:20.3","4qvvH-4g4eA:26.89"],["4QVV_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.68A","4qvvK-4g4eA:20.9;4qvvL-4g4eA:17.6","4qvvK-4g4eA:28.05;4qvvL-4g4eA:23.61"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.80A","4qvvV-4g4eA:22.0","4qvvV-4g4eA:26.89"],["4QVV_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.68A","4qvvY-4g4eA:10.7;4qvvZ-4g4eA:4.5","4qvvY-4g4eA:28.05;4qvvZ-4g4eA:23.61"],["4QVW_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.66A","4qvwK-4g4eA:21.0;4qvwL-4g4eA:17.6","4qvwK-4g4eA:28.05;4qvwL-4g4eA:23.61"],["4QVW_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.66A","4qvwY-4g4eA:11.7;4qvwZ-4g4eA:18.8","4qvwY-4g4eA:28.05;4qvwZ-4g4eA:23.61"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.81A","4qvyH-4g4eA:20.2","4qvyH-4g4eA:26.89"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  49","None","0.68A","4qvyK-4g4eA:21.0;4qvyL-4g4eA:17.7","4qvyK-4g4eA:28.51;4qvyL-4g4eA:23.61"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;VAL A  31;LYS A  33;GLY A  49;THR A  50","None","0.79A","4qvyK-4g4eA:21.0;4qvyL-4g4eA:17.7","4qvyK-4g4eA:28.51;4qvyL-4g4eA:23.61"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  49","None","0.67A","4qvyY-4g4eA:21.0;4qvyZ-4g4eA:4.7","4qvyY-4g4eA:28.51;4qvyZ-4g4eA:23.61"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;VAL A  31;LYS A  33;GLY A  49;THR A  50","None","0.78A","4qvyY-4g4eA:21.0;4qvyZ-4g4eA:4.7","4qvyY-4g4eA:28.51;4qvyZ-4g4eA:23.61"],["4QW0_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"THR A   1;ALA A  20;LYS A  33;THR A  50","None","0.98A","4qw0K-4g4eA:20.9","4qw0K-4g4eA:28.05"],["4QW0_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"THR A   1;ALA A  20;THR A  21;LYS A  33","None","0.57A","4qw0K-4g4eA:20.9","4qw0K-4g4eA:28.05"],["4QW0_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"THR A   1;ALA A  20;LYS A  33;THR A  50","None","0.98A","4qw0Y-4g4eA:10.7","4qw0Y-4g4eA:28.05"],["4QW0_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"THR A   1;ALA A  20;THR A  21;LYS A  33","None","0.57A","4qw0Y-4g4eA:10.7","4qw0Y-4g4eA:28.05"],["4QW1_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.65A","4qw1K-4g4eA:21.0;4qw1L-4g4eA:17.7","4qw1K-4g4eA:27.60;4qw1L-4g4eA:23.61"],["4QW1_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.99A","4qw1K-4g4eA:21.0;4qw1L-4g4eA:17.7","4qw1K-4g4eA:27.60;4qw1L-4g4eA:23.61"],["4QW1_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.65A","4qw1Y-4g4eA:10.8;4qw1Z-4g4eA:17.5","4qw1Y-4g4eA:27.60;4qw1Z-4g4eA:23.61"],["4QW1_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.99A","4qw1Y-4g4eA:10.8;4qw1Z-4g4eA:17.5","4qw1Y-4g4eA:27.60;4qw1Z-4g4eA:23.61"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.64A","4qw3K-4g4eA:20.8;4qw3L-4g4eA:17.6","4qw3K-4g4eA:27.19;4qw3L-4g4eA:23.61"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.02A","4qw3K-4g4eA:20.8;4qw3L-4g4eA:17.6","4qw3K-4g4eA:27.19;4qw3L-4g4eA:23.61"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.64A","4qw3Y-4g4eA:10.6;4qw3Z-4g4eA:18.7","4qw3Y-4g4eA:27.19;4qw3Z-4g4eA:23.61"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","1.02A","4qw3Y-4g4eA:10.6;4qw3Z-4g4eA:18.7","4qw3Y-4g4eA:27.19;4qw3Z-4g4eA:23.61"],["4QWU_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;LYS A  33;GLY A  48;GLY A  49","None","1.04A","4qwuK-4g4eA:20.1;4qwuL-4g4eA:17.5","4qwuK-4g4eA:28.05;4qwuL-4g4eA:23.61"],["4QWU_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.88A","4qwuK-4g4eA:20.1;4qwuL-4g4eA:17.5","4qwuK-4g4eA:28.05;4qwuL-4g4eA:23.61"],["4QWU_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;LYS A  33;GLY A  48;GLY A  49","None","0.98A","4qwuY-4g4eA:10.7;4qwuZ-4g4eA:18.8","4qwuY-4g4eA:28.05;4qwuZ-4g4eA:23.61"],["4QWU_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.87A","4qwuY-4g4eA:10.7;4qwuZ-4g4eA:18.8","4qwuY-4g4eA:28.05;4qwuZ-4g4eA:23.61"],["5BXN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.60A","5bxnK-4g4eA:21.1;5bxnL-4g4eA:17.4","5bxnK-4g4eA:28.05;5bxnL-4g4eA:23.61"],["5BXN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.99A","5bxnK-4g4eA:21.1;5bxnL-4g4eA:17.4","5bxnK-4g4eA:28.05;5bxnL-4g4eA:23.61"],["5BXN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.77A","5bxnV-4g4eA:22.0;5bxnW-4g4eA:20.2","5bxnV-4g4eA:31.46;5bxnW-4g4eA:22.33"],["5BXN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.61A","5bxnY-4g4eA:10.8;5bxnZ-4g4eA:18.7","5bxnY-4g4eA:28.05;5bxnZ-4g4eA:23.61"],["5BXN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A 162;ALA A  15;GLY A 125;GLY A 126;ALA A 129","None","0.99A","5bxnY-4g4eA:10.8;5bxnZ-4g4eA:18.7","5bxnY-4g4eA:28.05;5bxnZ-4g4eA:23.61"],["5D0X_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.57A","5d0xK-4g4eA:21.0;5d0xL-4g4eA:17.6","5d0xK-4g4eA:27.60;5d0xL-4g4eA:23.61"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.80A","5d0xV-4g4eA:22.0","5d0xV-4g4eA:26.89"],["5D0X_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.57A","5d0xY-4g4eA:10.8;5d0xZ-4g4eA:18.8","5d0xY-4g4eA:27.60;5d0xZ-4g4eA:23.61"],["5DZK_3_BEZ3801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;BEZ-LEU-LEU","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"LEU A  95;ILE A 105;GLY A  45;ILE A 120","None","0.80A","5dzk3-4g4eA:undetectable;5dzkm-4g4eA:undetectable","5dzk3-4g4eA:2.11;5dzkm-4g4eA:21.74"],["5DZK_W_BEZW801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"ILE A 105;GLY A  45;ILE A 120;LEU A  95","None","0.87A","5dzkB-4g4eA:undetectable;5dzkI-4g4eA:undetectable;5dzkW-4g4eA:undetectable","5dzkB-4g4eA:22.59;5dzkI-4g4eA:21.74;5dzkW-4g4eA:2.11"],["5DZK_X_BEZX801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;BEZ-LEU-LEU","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"ILE A 105;GLY A  45;ILE A 120;LEU A  95","None","0.86A","5dzki-4g4eA:undetectable;5dzkj-4g4eA:undetectable;5dzkx-4g4eA:undetectable","5dzki-4g4eA:21.74;5dzkj-4g4eA:21.74;5dzkx-4g4eA:2.11"],["5DZK_Z_BEZZ801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;BEZ-LEU-LEU","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",4,"ILE A 105;GLY A  45;ILE A 120;LEU A  95","None","0.79A","5dzkl-4g4eA:undetectable;5dzkz-4g4eA:undetectable","5dzkl-4g4eA:21.74;5dzkz-4g4eA:2.11"],["5L5Z_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.73A","5l5zH-4g4eA:20.8;5l5zI-4g4eA:19.6","5l5zH-4g4eA:26.89;5l5zI-4g4eA:22.33"],["5L5Z_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.67A","5l5zK-4g4eA:21.0;5l5zL-4g4eA:17.5","5l5zK-4g4eA:27.65;5l5zL-4g4eA:23.61"],["5L5Z_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.73A","5l5zV-4g4eA:22.0;5l5zW-4g4eA:20.1","5l5zV-4g4eA:26.89;5l5zW-4g4eA:22.33"],["5L5Z_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.67A","5l5zY-4g4eA:21.0;5l5zZ-4g4eA:18.9","5l5zY-4g4eA:27.65;5l5zZ-4g4eA:23.61"],["5L66_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.61A","5l66K-4g4eA:21.1;5l66L-4g4eA:17.7","5l66K-4g4eA:23.61;5l66L-4g4eA:23.61"],["5L66_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48","None","0.62A","5l66Y-4g4eA:21.1;5l66Z-4g4eA:18.9","5l66Y-4g4eA:23.61;5l66Z-4g4eA:23.61"],["5LF3_H_BO2H306_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;ALA A  47;GLY A  48","None","0.65A","5lf3H-4g4eA:22.0;5lf3I-4g4eA:19.8","5lf3H-4g4eA:24.57;5lf3I-4g4eA:23.81"],["5LF3_K_BO2K305_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-1","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",7,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49;TYR A 161","None","0.69A","5lf3K-4g4eA:21.7;5lf3L-4g4eA:18.8","5lf3K-4g4eA:26.42;5lf3L-4g4eA:24.77"],["5LF3_V_BO2V303_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;ALA A  47;GLY A  48","None","0.70A","5lf3V-4g4eA:22.0;5lf3W-4g4eA:19.7","5lf3V-4g4eA:24.57;5lf3W-4g4eA:23.81"],["5LF3_Y_BO2Y305_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-1","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",7,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49;TYR A 161","None","0.70A","5lf3Y-4g4eA:21.7;5lf3Z-4g4eA:18.8","5lf3Y-4g4eA:26.42;5lf3Z-4g4eA:24.77"],["5LF7_H_6V8H305_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;ALA A  47;GLY A  48","None","0.67A","5lf7H-4g4eA:22.0;5lf7I-4g4eA:19.7","5lf7H-4g4eA:24.57;5lf7I-4g4eA:23.81"],["5LF7_K_6V8K305_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",7,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  48;GLY A  49","None","0.75A","5lf7K-4g4eA:21.7;5lf7L-4g4eA:18.8","5lf7K-4g4eA:26.42;5lf7L-4g4eA:24.77"],["5LF7_V_6V8V303_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",5,"THR A   1;ALA A  20;THR A  21;ALA A  47;GLY A  48","None","0.70A","5lf7V-4g4eA:22.0;5lf7W-4g4eA:19.8","5lf7V-4g4eA:24.57;5lf7W-4g4eA:23.81"],["5LF7_Y_6V8Y306_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-5","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",7,"THR A   1;ALA A  20;THR A  21;VAL A  31;LYS A  33;GLY A  48;GLY A  49","None","0.75A","5lf7Y-4g4eA:21.7;5lf7Z-4g4eA:18.8","5lf7Y-4g4eA:26.42;5lf7Z-4g4eA:24.77"],["6HWD_K_BO2K301_0","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.62A","6hwdK-4g4eA:21.0;6hwdL-4g4eA:17.7","6hwdK-4g4eA:22.09;6hwdL-4g4eA:19.05"],["6HWD_Y_BO2Y301_0","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4g4e","ATP-DEPENDENT PROTEASE SUBUNIT HSLV","Escherichia coli",6,"THR A   1;ALA A  20;THR A  21;LYS A  33;GLY A  48;GLY A  49","None","0.61A","6hwdY-4g4eA:10.9;6hwdZ-4g4eA:17.5","6hwdY-4g4eA:22.09;6hwdZ-4g4eA:19.05"]]